Positioning no disclosures inside 60 days, left as found
Options put/call open interest 4.74, read 2026-10-24
Ethical does not pass the values gate
Price130.19 USD
Fair value163.00
Ethical score30.0/100
Our investment reviews on this name
2026-10-17Read Accumulation130.97-0.6% to today Markdown gives way to Accumulation
2026-10-02Read Markdown131.34-0.9% to today ✓Accumulation gives way to Markdown
2026-09-03Read Accumulation132.32-1.6% to today Markup gives way to Accumulation after a 9% rise in 4 weeks
2026-08-03Read Markup121.90+6.8% to today ✓Distribution gives way to Markup after a 12% rise in 5 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Jackson Financial Inc. holds its Accumulation at $130.19. The statistical read favours the sellers, held for 48 days.
As held on the ledger · 2026-10-23
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 48 days
Price at the screen
$130.19
Valuation
141.34 trailing · 4.07 forward price to earnings
Values screen
FAIL· score 30.0
Beta
1.32
The Workings
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: insurance
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Prohibited keyword in sector/industry: insurance
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Jackson Financial does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when JXN's ethical verdict changes
Today JXN does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 25.2% margin of safety to the base estimate.
Third-party analyst targets: 4 covering, consensus Buy. The average target sits +12% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
Picture retirees in the US handing over savings for annuity promises that must be backed by complex investment portfolios and regulatory capital. Jackson Financial runs exactly that machine across retail, institutional and legacy blocks. We pass because the business sits in insurance, a sector our screen prohibits outright, regardless of the 4.5x forward earnings multiple or the slim margin of safety to our $140 fair value.
Revenue is already falling 23 percent, profit margins sit at minus 6 percent and return on equity is negative 3 percent. Those figures sit far from any durable moat and the opportunity rating is none. Analyst chatter calling it a buy at a $134 median target does not change the ethical red line.
The low multiple may simply reflect peak earnings in a rate-sensitive product line rather than a bargain. Currency, regulation and longevity risk remain live even if the valuation looks compressed. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
JXN trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-29Accumulation$130.19+1.2%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it hold, with a mean price target of $123. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Accumulation$128.62+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it hold, with a mean price target of $123. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Accumulation$128.62+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it hold, with a mean price target of $123. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Accumulation$128.62-1.8%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 13% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it hold, with a mean price target of $123.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it hold, with a mean price target of $123.
2026-10-02Markdown · changed$131.34-0.7%Entry 6
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it hold, with a mean price target of $123.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it hold, with a mean price target of $123.
2026-08-03Markup · changed$121.90+12.2%Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it hold, with a mean price target of $123.
2026-07-18Distribution$108.69+0.0%Entry 3
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it hold, with a mean price target of $123.
2026-07-03Distribution$108.69+0.0%Entry 2
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
